TW200942167A - Novel formulation - Google Patents
Novel formulation Download PDFInfo
- Publication number
- TW200942167A TW200942167A TW098101274A TW98101274A TW200942167A TW 200942167 A TW200942167 A TW 200942167A TW 098101274 A TW098101274 A TW 098101274A TW 98101274 A TW98101274 A TW 98101274A TW 200942167 A TW200942167 A TW 200942167A
- Authority
- TW
- Taiwan
- Prior art keywords
- disinfecting formulation
- disinfecting
- formulation
- acid
- polymer
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 83
- 238000009472 formulation Methods 0.000 title claims abstract description 76
- 229920000642 polymer Polymers 0.000 claims abstract description 98
- 230000002378 acidificating effect Effects 0.000 claims abstract description 48
- 239000003945 anionic surfactant Substances 0.000 claims abstract description 33
- 239000007788 liquid Substances 0.000 claims abstract description 14
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical group [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims abstract description 10
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims abstract description 10
- 125000000129 anionic group Chemical group 0.000 claims abstract description 9
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid group Chemical group C(\C=C/C(=O)O)(=O)O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims abstract description 7
- 230000000249 desinfective effect Effects 0.000 claims description 46
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 33
- 239000002253 acid Substances 0.000 claims description 25
- -1 propylene allyl ether Chemical compound 0.000 claims description 24
- 239000000463 material Substances 0.000 claims description 16
- 229910052739 hydrogen Inorganic materials 0.000 claims description 15
- 239000001257 hydrogen Substances 0.000 claims description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 13
- 150000003839 salts Chemical class 0.000 claims description 12
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 11
- 229910052708 sodium Inorganic materials 0.000 claims description 11
- 239000011734 sodium Substances 0.000 claims description 11
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 10
- 125000000217 alkyl group Chemical group 0.000 claims description 10
- 229920002125 Sokalan® Polymers 0.000 claims description 9
- 229920001577 copolymer Polymers 0.000 claims description 9
- 244000005700 microbiome Species 0.000 claims description 9
- 150000002431 hydrogen Chemical group 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 7
- 239000000126 substance Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 5
- 150000008064 anhydrides Chemical class 0.000 claims description 5
- 150000001768 cations Chemical class 0.000 claims description 5
- 150000002148 esters Chemical class 0.000 claims description 5
- 241000894006 Bacteria Species 0.000 claims description 4
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 claims description 4
- 125000003545 alkoxy group Chemical group 0.000 claims description 4
- 229920001519 homopolymer Polymers 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- KPSSIOMAKSHJJG-UHFFFAOYSA-N neopentyl alcohol Chemical compound CC(C)(C)CO KPSSIOMAKSHJJG-UHFFFAOYSA-N 0.000 claims description 4
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 claims description 4
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 4
- 239000011976 maleic acid Substances 0.000 claims description 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 3
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 239000000460 chlorine Substances 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- ORTFAQDWJHRMNX-UHFFFAOYSA-N hydroxidooxidocarbon(.) Chemical compound O[C]=O ORTFAQDWJHRMNX-UHFFFAOYSA-N 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 239000013543 active substance Substances 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000004575 stone Substances 0.000 claims 1
- 239000004141 Sodium laurylsulphate Substances 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 10
- 210000003491 skin Anatomy 0.000 description 10
- 239000000243 solution Substances 0.000 description 8
- 241000700605 Viruses Species 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 125000004432 carbon atom Chemical group C* 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 6
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 6
- 239000002585 base Substances 0.000 description 5
- UPBDXRPQPOWRKR-UHFFFAOYSA-N furan-2,5-dione;methoxyethene Chemical compound COC=C.O=C1OC(=O)C=C1 UPBDXRPQPOWRKR-UHFFFAOYSA-N 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- 239000003981 vehicle Substances 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 159000000000 sodium salts Chemical class 0.000 description 4
- URDCARMUOSMFFI-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(2-hydroxyethyl)amino]acetic acid Chemical compound OCCN(CC(O)=O)CCN(CC(O)=O)CC(O)=O URDCARMUOSMFFI-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 230000000840 anti-viral effect Effects 0.000 description 3
- 125000004122 cyclic group Chemical group 0.000 description 3
- 239000000645 desinfectant Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 239000001087 glyceryl triacetate Substances 0.000 description 3
- 235000013773 glyceryl triacetate Nutrition 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 235000021317 phosphate Nutrition 0.000 description 3
- 229920005862 polyol Polymers 0.000 description 3
- 150000003077 polyols Chemical class 0.000 description 3
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 3
- 125000000542 sulfonic acid group Chemical group 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 229960002622 triacetin Drugs 0.000 description 3
- WLAMNBDJUVNPJU-UHFFFAOYSA-N 2-methylbutyric acid Chemical compound CCC(C)C(O)=O WLAMNBDJUVNPJU-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical group [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 229920006318 anionic polymer Polymers 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 125000002843 carboxylic acid group Chemical group 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 229920006037 cross link polymer Polymers 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 208000037797 influenza A Diseases 0.000 description 2
- 239000002563 ionic surfactant Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 239000004584 polyacrylic acid Substances 0.000 description 2
- 229920000570 polyether Polymers 0.000 description 2
- 229910052700 potassium Chemical group 0.000 description 2
- 239000011591 potassium Chemical group 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- ZUFONQSOSYEWCN-UHFFFAOYSA-M sodium;2-(methylamino)acetate Chemical compound [Na+].CNCC([O-])=O ZUFONQSOSYEWCN-UHFFFAOYSA-M 0.000 description 2
- 241000894007 species Species 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-L sulfite Chemical compound [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 2
- 229940104261 taurate Drugs 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 229960003500 triclosan Drugs 0.000 description 2
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- 239000004711 α-olefin Substances 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- VVMKVFQYONGBPV-MKWAYWHRSA-N (z)-4-butoxy-4-oxobut-2-enoic acid;methoxyethene Chemical compound COC=C.CCCCOC(=O)\C=C/C(O)=O VVMKVFQYONGBPV-MKWAYWHRSA-N 0.000 description 1
- DKPQIOQEAATZQU-UHFFFAOYSA-N 1,4-dioctoxy-1,4-dioxobutane-2-sulfonic acid;sodium Chemical compound [Na].[Na].CCCCCCCCOC(=O)CC(S(O)(=O)=O)C(=O)OCCCCCCCC DKPQIOQEAATZQU-UHFFFAOYSA-N 0.000 description 1
- GXQHZLJGPBPXRJ-UHFFFAOYSA-N 1-(2-methylaziridin-1-yl)prop-2-en-1-one Chemical compound CC1CN1C(=O)C=C GXQHZLJGPBPXRJ-UHFFFAOYSA-N 0.000 description 1
- FKKAGFLIPSSCHT-UHFFFAOYSA-N 1-dodecoxydodecane;sulfuric acid Chemical compound OS(O)(=O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC FKKAGFLIPSSCHT-UHFFFAOYSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- ALOVPZWOOLXQEU-UHFFFAOYSA-N 2-[2-dodecoxyethyl(2-hydroxyethyl)amino]ethanol;sulfuric acid Chemical compound OS(O)(=O)=O.CCCCCCCCCCCCOCCN(CCO)CCO ALOVPZWOOLXQEU-UHFFFAOYSA-N 0.000 description 1
- XMIIGOLPHOKFCH-UHFFFAOYSA-N 3-phenylpropionic acid Chemical compound OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 1
- ATVJXMYDOSMEPO-UHFFFAOYSA-N 3-prop-2-enoxyprop-1-ene Chemical compound C=CCOCC=C ATVJXMYDOSMEPO-UHFFFAOYSA-N 0.000 description 1
- OSDLLIBGSJNGJE-UHFFFAOYSA-N 4-chloro-3,5-dimethylphenol Chemical compound CC1=CC(O)=CC(C)=C1Cl OSDLLIBGSJNGJE-UHFFFAOYSA-N 0.000 description 1
- LIFHMKCDDVTICL-UHFFFAOYSA-N 6-(chloromethyl)phenanthridine Chemical compound C1=CC=C2C(CCl)=NC3=CC=CC=C3C2=C1 LIFHMKCDDVTICL-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 239000004135 Bone phosphate Substances 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical group [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241000709661 Enterovirus Species 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 229920003135 Eudragit® L 100-55 Polymers 0.000 description 1
- 229920003134 Eudragit® polymer Polymers 0.000 description 1
- 241000237858 Gastropoda Species 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 235000017858 Laurus nobilis Nutrition 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical group CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 241001134777 Sulfobacillus Species 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 244000125380 Terminalia tomentosa Species 0.000 description 1
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 239000005083 Zinc sulfide Substances 0.000 description 1
- ZIWUUXFBQHYONB-UHFFFAOYSA-N [Na].C(CCCCCCCCCCCCCCCCC)S(=O)(=O)OCCCCCCCCCC Chemical compound [Na].C(CCCCCCCCCCCCCCCCC)S(=O)(=O)OCCCCCCCCCC ZIWUUXFBQHYONB-UHFFFAOYSA-N 0.000 description 1
- VEUACKUBDLVUAC-UHFFFAOYSA-N [Na].[Ca] Chemical compound [Na].[Ca] VEUACKUBDLVUAC-UHFFFAOYSA-N 0.000 description 1
- WDJHALXBUFZDSR-UHFFFAOYSA-M acetoacetate Chemical compound CC(=O)CC([O-])=O WDJHALXBUFZDSR-UHFFFAOYSA-M 0.000 description 1
- 125000004018 acid anhydride group Chemical group 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- BTBJBAZGXNKLQC-UHFFFAOYSA-N ammonium lauryl sulfate Chemical compound [NH4+].CCCCCCCCCCCCOS([O-])(=O)=O BTBJBAZGXNKLQC-UHFFFAOYSA-N 0.000 description 1
- 229940063953 ammonium lauryl sulfate Drugs 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 229940027983 antiseptic and disinfectant quaternary ammonium compound Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000008135 aqueous vehicle Substances 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- JXLHNMVSKXFWAO-UHFFFAOYSA-N azane;7-fluoro-2,1,3-benzoxadiazole-4-sulfonic acid Chemical compound N.OS(=O)(=O)C1=CC=C(F)C2=NON=C12 JXLHNMVSKXFWAO-UHFFFAOYSA-N 0.000 description 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Substances C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229940096529 carboxypolymethylene Drugs 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 229960005443 chloroxylenol Drugs 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000012864 cross contamination Methods 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000000412 dendrimer Substances 0.000 description 1
- 229920000736 dendritic polymer Polymers 0.000 description 1
- 229910052805 deuterium Inorganic materials 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 1
- SMVRDGHCVNAOIN-UHFFFAOYSA-L disodium;1-dodecoxydodecane;sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC SMVRDGHCVNAOIN-UHFFFAOYSA-L 0.000 description 1
- PMPJQLCPEQFEJW-HPKCLRQXSA-L disodium;2-[(e)-2-[4-[4-[(e)-2-(2-sulfonatophenyl)ethenyl]phenyl]phenyl]ethenyl]benzenesulfonate Chemical group [Na+].[Na+].[O-]S(=O)(=O)C1=CC=CC=C1\C=C\C1=CC=C(C=2C=CC(\C=C\C=3C(=CC=CC=3)S([O-])(=O)=O)=CC=2)C=C1 PMPJQLCPEQFEJW-HPKCLRQXSA-L 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- GDCRSXZBSIRSFR-UHFFFAOYSA-N ethyl prop-2-enoate;2-methylprop-2-enoic acid Chemical compound CC(=C)C(O)=O.CCOC(=O)C=C GDCRSXZBSIRSFR-UHFFFAOYSA-N 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- OOZYQDUFRNYGBN-UHFFFAOYSA-N hexane-3-sulfonic acid Chemical compound CCCC(CC)S(O)(=O)=O OOZYQDUFRNYGBN-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229940035535 iodophors Drugs 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 229920005684 linear copolymer Polymers 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 229940048195 n-(hydroxyethyl)ethylenediaminetriacetic acid Drugs 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229910052755 nonmetal Inorganic materials 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 150000002923 oximes Chemical class 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000006179 pH buffering agent Substances 0.000 description 1
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920000172 poly(styrenesulfonic acid) Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229940005642 polystyrene sulfonic acid Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 238000011012 sanitization Methods 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 150000003385 sodium Chemical class 0.000 description 1
- 229940079776 sodium cocoyl isethionate Drugs 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- 229940104256 sodium taurate Drugs 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 1
- 229920001897 terpolymer Polymers 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000003253 viricidal effect Effects 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 229910052984 zinc sulfide Inorganic materials 0.000 description 1
- DRDVZXDWVBGGMH-UHFFFAOYSA-N zinc;sulfide Chemical compound [S-2].[Zn+2] DRDVZXDWVBGGMH-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/48—Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/02—Saturated carboxylic acids or thio analogues thereof; Derivatives thereof
- A01N37/04—Saturated carboxylic acids or thio analogues thereof; Derivatives thereof polybasic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/06—Unsaturated carboxylic acids or thio analogues thereof; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/02—Anionic compounds
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/02—Anionic compounds
- C11D1/12—Sulfonic acids or sulfuric acid esters; Salts thereof
- C11D1/14—Sulfonic acids or sulfuric acid esters; Salts thereof derived from aliphatic hydrocarbons or mono-alcohols
- C11D1/146—Sulfuric acid esters
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/02—Anionic compounds
- C11D1/12—Sulfonic acids or sulfuric acid esters; Salts thereof
- C11D1/29—Sulfates of polyoxyalkylene ethers
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/37—Polymers
- C11D3/3746—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
- C11D3/3757—(Co)polymerised carboxylic acids, -anhydrides, -esters in solid and liquid compositions
- C11D3/3761—(Co)polymerised carboxylic acids, -anhydrides, -esters in solid and liquid compositions in solid compositions
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Health & Medical Sciences (AREA)
- Dentistry (AREA)
- Agronomy & Crop Science (AREA)
- Environmental Sciences (AREA)
- Zoology (AREA)
- Plant Pathology (AREA)
- Pest Control & Pesticides (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Detergent Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Description
200942167 六、發明說明: 【發明所屬之技術領域】 本發明係關於消毒調配物,其尤其用於清潔人類皮膚 (諸如手)’具有可對抗有害微生物(諸如細菌及病毒)之活 性。 【先前技術】
隨著醫院中如MRS A之抗藥性生物感染事件之增加,及 密閉區間(諸如遊輪)中公開感染事件之確認,手部衛生之 重要性近年來與日俱增。在醫院中,此類生物之一般傳播 途徑係經由保健工作者之手。世界衛生組織(WH〇)已對手 部衛生製定指南:「手部衛生保健之WHO指南
Guidelines on Hand Hygiene in Healthcare) j 高紙草案 2007(Advanced Draft 2007)(文中稱為 WHO 指南)。根據 WHO扣南,有兩大類微生物(即固有性及暫時性微生物)寄 居於人體皮膚中。固有性生物係寄居於角質層表面細胞 下,且亦在皮膚表面上。表皮葡萄球菌為主要菌種…般 而言’固有性生物較不可能舆感染相關,但可能引起無菌 體腔、眼睛或損傷性皮膚之感染。群聚在皮膚表層之暫時 性生物為最常與事關感染之保健相關之生物,常見的暫時 :微生物諸如為金黃色葡萄球菌、其他葡萄球菌、銀難梭 ^、大腸桿菌及各種病毒諸如輪狀病毒、流感病毒及鼻病 作爲具有遭感染之手部㈣如醫院護理 微生物傳播及交叉污染 卜有之人士對 '、+裘,使用消毒調配物有效地清 137I86.doc 200942167 洗局部無生命表面,諸如家具及工作者之手,為一般最常 建議的方法。此等消毒調配物一般係呈可方便施用於該等 表面之流動液體或凝膠之形式,此等調配物之適宜黏度在 此領域中已為人熟知。已知多種消毒調配物,諸如WO-A-2004/101724、WO-A-2004/101725 及 WO-A-2005/110357 中 揭示者爲典型實例。一些已知的消毒調配物係以界面活性 劑(諸如月桂基硫酸鈉)及某些酸性聚合物(諸如所謂的卡波 姆(Carbopol))之組合為主成分。此等調配物(例如)揭示於 WO-A-1999/24012、GB-A-2 393 908、EP-A-1 090 631 及 WO-A-2005/04663 中。 WHO指南亦列出已被用於手部消毒以嘗試使皮膚免受有 害生物污染之多種物質,包含肥皂、醇類、洗必太 (chlorhexidine)、氣二曱苯盼(chloroxylenol)、六氣酌·、 蛾、峨仿(iodophors)、四級铵化合物、三氯生(triclosan)、 次氯酸鹽等。此等物質中一些具有危險性,例如醇為易燃 性及碘與其他鹵素具有腐蝕性或會釋放(例如)游離氯氣。 (例如)自申請者同在申請中的PCT/EP2007/057298、WO-A-03/039713及US-A-7,029,516中知曉,某些酸性聚合物具 有鈍化病毒之活性且可沉積於對於吾人而言作爲空氣過濾 器系統的纖維狀基質上。出乎意料地發現經由以特定的新 穎方法調配酸性聚合物,可提供具有抗病毒及抗細菌活性 之消毒調配物。本發明之一目的為在提供改良的消毒調配 物時利用此發現,該改良的消毒調配物例如具有改良效 力,或對抗更廣範圍微生物之效力,或避免與已知的消毒 137186.doc 200942167 調配物有關之缺點。 【發明内容】 根據本發月之第―態樣’一種新消毒調配物包含—酸性 聚合物和-陰離子界面活性劑於—液體媒劑中之溶液。 如文中所用’術語「消毒」係指鈍化(例如經由殺死或 ’ ^"其他方式)潛在有害的病原體(諸如細菌或病毒)。本發明 ' m調配物可另具有利於自表面移除污物之清潔作用。 Φ 如文中所用,術「酸性聚合物」包含沿其主鏈具有酸 性基團(例如作為側基)之聚合物。適宜的酸性基團為缓酸 基團。該酸性聚合物可為交聯或線性的。一般而言,對於 本申請案,非交聯(例如線性)聚合物為較佳。此尤其係因 為較之父如聚合物’非交聯線性結構可提供更多可利用 .的⑺⑽基目且非父聯聚合物亦更易於溶解,及因此使 用在文中揭示的製備方法中。 酸性聚合物可包含聚_(羧酸)聚合物。 • 聚_(叛酸)聚合物典型上為於其結構中包含-COOH基團、 或衍生物基團(諸如酸-酐基團)、易裂解的_旨基或易裂 解產生-COOH基團之成鹽_c〇〇H基團的聚合物。 聚-(羧酸)聚合物可具有直接與其主鏈連接之_c〇〇h基團 -(或衍生物基團)’或該聚合物可為所謂的接枝或樹枝狀聚 合物,其中-COOH(或衍生物)基團係附接於從主鏈分支的 側鏈。 例如,聚-(叛酸)聚合物可於其結構中包含: -[-CRVCOOH-]- 137186.doc 200942167 單元,其中R1較佳為氫,或RWw基、Ci‘氧基或 C 1.3經烧基。 該聚-(羧酸)聚合物中之一類型包含於其結構中具有單 元: ’、 -[-C^R^CR^COOH-]- 之聚合物’其中RiR3較佳獨立地為氫,或可為基 或心·3烷氧基。例如,此聚合物可包含聚_(羧基乙婦基)聚 合物,例如化學式CR2R3 = CRl.C〇〇H之單體化合物之聚合 物’其中該等取代基係如上定義。此聚合物可包含丙烯酸 或甲基丙稀酸之聚合才勿,即$丙烯酸或聚甲基丙稀酸,例 如線性聚丙烯酸及聚曱基丙烯酸均聚物及共聚物。此聚合 物之一實例為聚羧乙烯(carboxypolymethylene)。市售聚丙
烯酸之一實例為具有約30,000之分子量之材料GoodRiteTM K-702。市售聚丙烯酸(作為其鈉鹽)之—實例為亦具有約 30,000之分子量之材料G〇〇d_RiteTM κ_765。聚丙烯酸聚合 物可於市面以商品名稱Carb〇merTM購得(其被歸類為合成 聚合物),其或者被使用作為乳液安定劑與水性黏度增加 劑。 此類聚合物(例如)揭示於US_A_2,798,053中即「羧基 單體(諸如丙烯酸、馬來酸或酐等)與特定比例之多元醇之 聚烯基聚醚共聚合,該多元醇之聚烯基聚醚每個分子包含 多於一個烯基醚基團,該母多元醇包含至少4個碳原子及 至少3個經基。」 另一類型之聚_(羧酸)為交聯聚_(羧酸)聚合物。此類實例 137186.doc 200942167 包含以(例如)新戊四醇、蔗糖或丙烯之烯丙醚交聯的丙烯 酸之均聚物,例如購自B.F.Goodrich公司的商品名 「Carbopol」之材料,諸如特定的Carbopol包含Carbopol 934、940、980、1382、Carbopol ETD 2020、ETD 2050、 Ultrez 20及 21。 該聚-(羧酸)聚合物之另一類型可於其結構中包含相鄰的 -[-CR^COOH-]- 單元(其中R1係如上定義),例如,基於馬來酸部分之聚合 物,其一般包含-[-CH.COOH_CH.COOH-]-單元、及/或該 等單元之鹽或酯、或酐形式之該等單元,其中相鄰碳原子 上的C00H基團可環化形成-CH.C0-0-C0.CH-環系統,此 等衍生物易於水解形成相應的游離酸。 該聚-(羧酸)聚合物之一種類型可包含具有位於相鄰聚合 物鏈碳原子上之羧酸基團對之單元。例如,此等聚合物可 於其結構中包含單元: -[-cr'r2-cr3r4-cr5.cooh-cr6.cooh-]- > 其中R1、R2、R3、R4、R5及R6獨立地為氫(較佳)或(^-3烷 基或Cm烷氧基,R1及R2較佳為氫,R3為氳,R4為甲氧 基,及R5及R6為氫,或於其結構中保留COOH基團之其衍 生物,或易水解為C00H基團之基團。此聚-(羧酸)聚合物 為基於甲基乙烯基醚與馬來酸酐之共聚物之聚合物。此等 聚合物可以商品名稱GantrezTM購得。 此聚合物之一實例於其結構中包含: -[-CH2-CH.OCH3-CH.COOH-CH.COOH-]- 137186.doc 200942167 單元。 此等聚合物可為線性聚合物,或交聯聚合物。此類型之 線性、非交聯聚合物可以商品名稱Gantrez™ S (CAS # 25153-4-69)購得,例如具有約700,000分子量之Gantrez™ S-96,具有約1,200,000分子量之Gantrez™ S-97。此等 Gantrez聚合物為較佳。該等GantrezTM聚合物可以水溶液 購得,其以此形式可用於本發明之調配物中。 此類型之交聯聚合物亦可以品名稱購得。 該酸之衍生物之一實例為酐,即,其中兩相鄰的-COOH 基團環化形成
環系統,該酐易水解形成對應的游離酸。此等聚合物可以 商品名稱Gantrez™ AN (CAS # 9011-16-9)購得,例如 Gantrez™ AN-119 ' Gantrez™ AN-903 ' Gantrez™ AN-139、Gantrez™ AN-169。 衍生物之另一實例為部分鹽,例如,其中一些游離的-COOH基團經轉化為I族或II族金屬之金屬鹽,諸如分別為 鈉或鈣鹽,或混合的鈉-鈣鹽。此聚合物可以商品名稱 Gantrez™ MS,例如Gantrez™ MS-955(CAS # 62386-95-2) 購得。 此酸之衍生物之另一實例為部分酯,其中一些游離的-COOH基團經Cw烷基(例如乙基或正丁基)酯化。此等聚合 137186.doc -8 - 200942167 物可以商品名稱Gantrez™ ES,例如Gantrez™ ES-225 (CAS # 25087-06-03)或 Gantrez™ ES-425(CAS # 25119-68-0) 購得。一般而言,此第二類型之聚合物具有20〇,〇〇〇_ 2,000,000範圍内之分子量。 在本發明之消毒調配物中,經發現其結構中包含相鄰的 -[-CR'.COOH-]- * 單元(其中R1係如上定義)之聚-(羧酸)聚合物,例如基於馬 ©來酸部分之聚合物’諸如上述的GantrezTM材料,因其當與 陰離子界面活性劑結合時的黏度,因而相對於(例如)基於 如CarbopoFM類型材料之本發明消毒調配物,其具有在其 所施用之表面上可維持更長時間的優勢。此更長之維持可 導致在表面上的延長活性。此等聚合物之另一優勢在於其 比(例如)基於CarbopolTM類型酸性聚合物之消毒調配物更 易流動、更易喷霧及可進入更為侷限之空間。 其他適宜的聚-(羧酸)聚合物包含Ci〇3◦烷基丙烯酸酯與 • 一或多種化學式r4r5c=cR6-coo R7之單體化合物之共聚 物,其中R4、R5 ' R6及R7分別獨立選自氫或Ci5烷基,尤 其是甲基、乙基或丙基。此類單體化合物之實例包含丙烯 ' 酸酯及甲基丙烯酸酯。 • 其他適宜的聚-(羧酸)聚合物包含基於化學式 hl^CsCRs-COO R4之化合物之陰離子聚合物,其中Ri、 R2、R3及R4分別獨立選自氫或Ci5烷基,尤其係曱基、乙 基或丙基。此類聚合物之實例為基於甲基丙婦酸及具有缓 酸官能基的丙稀酸乙醋之彼等,其等可以商品名稱 137186.doc 200942167
Eudragit」自Rohm GmbH & Co購得。特定等級包含 Eudragit L100-55、L30-D-55、Ll〇〇、S100 及 FS 30D。 其他適宜的酸性聚合物可為併入其他酸基(諸如確酸基) 之聚合物。併入磺酸基之酸性聚合物之實例為丙烯酸或曱 基丙烯酸與磺酸之共聚物(例如線性共聚物)。併入磺酸基 之此類聚合物可以其鹽形式(例如其鈉鹽)使用。丙稀酸與 磺酸之共聚物之一實例可以商品名稱G〇〇d-Rite™ K-776購 付。其他® 性聚合物可包含丙稀酸與續酸之共聚物。例 如’酸性5^合物可包含馬來酸、聚(2_丙稀酿胺基_2_曱基 丙磺酸)(「polyAMPS」)、及丙烯酸與2_丙烯醯胺基_2_甲 基丙磺酸之共聚物等之共聚物與三元共聚物。 聚本乙烯續酸可適用,例如可以商品名稱FlexanTM Η購 得的具有約120,000分子量、呈其鈉鹽形式之聚苯乙烯磺 酸可適用。 其他適宜的酸性聚合物據信包含聚乙烯膦酸。 經發現可有用於達成此處目的之酸性聚合物,發現其具 有30,000至2,000,000範圍内的分子量,但分子量似乎並不 關鍵,此可僅為示例性範圍。 較佳酸性聚合物為上述的Carb〇pol ETD 2020及 Gantrez™ S97。 一般而言,陰離子界面活性劑為具有親水性陰離子基團 及相關陽離子之化合物。此陽離子可為金屬(諸如鹼金屬) 或非金屬(諸如銨或四級銨)。_般而言,此等陰離子界面 活性劑包含親水性陰離子基團及呈鹽形式之陽離子。此陰 137186.doc 200942167 離子界面活性劑較佳包含有機親水性陰離子基團之納鹽。 有機親水性陰離子基團宜為磺酸基或羧酸基。 此陰離子界面活性劑化合物較佳具有化學式
CnH2n+l-Z M+ <1) 其中η為8至20’以10至15較佳,2為8〇3或叫,為鈉 • 核。此類型之-較佳陰離子界面活性劑為月桂基硫酸鈉 * 0=12,Z為 S04,Μ為鈉)。 ❿ 其他適宜的陰離子界面活性劑為化學式(11)之彼等:
CnH2n+l-X-CmH2m-Z' Μ+ (II) 其中n+m為8至20, X為_〇·或_c〇 〇_,2為8〇3或3〇4 ,且m 為鈉或鉀。此類型之一較佳陰離子界面活性劑為椰油醯基 羥乙磺酸鈉(n=9,m=2,X為C0.0,2為8〇3,M為鈉)。化 學式(Π)之另一陰離子界面活性劑為月桂基醚硫酸鈉。 其他適宜的陰離子界面活性劑為化學式(ΙΠ)之彼等: CnH2n+i-CO.NR.-CmH2m-Z' Μ+ (ΠΙ) ❹ 其中n&m分別為1或更大,n+m為8至20,R為Cw烷基,Ζ 為CO.O、SO3或S〇4,且Μ為鈉或鉀。此類型陰離子界面 活性劑較佳為月桂酿基肌胺酸納(n= j 1,r為甲基,i, Μ為納),及甲基椰油醯基牛磺酸鈉(尺為曱基,m=2,z為 . S〇3,Μ為鈉)。 其他陰離子界面活性劑為烯烴磺酸鹽(諸如α_烯烴硫酸 鹽)’諸如市售材料Bi〇tergeTM As-40,其為(:14.16磺酸鹽之 納鹽。 其他適宜的陰離子界面活性劑包含曱基月桂醯基牛磺酸 137186.doc 200942167 納、曱基硬脂醯基牛磺酸鈉及曱基棕櫚醯基牛磺酸鈉(及 其不同烧鏈長度之類似物)、月桂基硫酸銨、月桂基醚硫 酸錄、椰油醯基肌胺酸鈉、月桂基硫酸三乙醇胺、月桂基 醚硫酸三乙醇胺、油酸醯胺磺基琥珀酸二鈉、月桂基醚磺 基破拍酸二鈉、二辛基磺基琥珀酸二鈉。其他適宜的陰離 子界面活性劑種類包含烷芳基磺酸鹽、烷基琥珀酸鹽、烷 基磺基琥珀酸鹽、N-烷醯基肌胺酸鹽、烷基磷酸鹽、烷基 醚磷酸鹽、α_烯烴磺酸鹽及醯基甲基牛磺酸鹽(尤其是 鈉、鎮、銨與單、二及三乙醇胺鹽前面之烷基可包含8 至20個碳原子。烷基醚硫酸鹽及烷基醚磷酸鹽可每分子包 含1至10個環氧乙烷或環氧丙烷單元。 酉文性聚合物與陰離子界面活性劑之一較佳組合為
CarbopolTM ETD 2020或 Gantrez™ S97,與月桂基硫酸鈉或 α-烯煙硫酸鹽陰離子界面活性劑(諸如市售材料Bi〇terge
As-40,一種在酸性pH下穩定的水溶性α•稀烴界面活性 劑)。 在本發明新調配物之一實施例中,酸性聚合物及陰離子 界面活性劑可適宜地以酸性聚合物:陰離子界面活性劑之 重量%比為1-2:2-1 ’適宜地以1:1.5 +/_ 〇·2共同存於溶液 中。適宜地,在溶液中,酸性聚合物係以U,較佳以 2 +/- 0.2重量%存在,且陰離子界面活性劑係以〇· 1 _4重量 %,較佳以1.5 +/- 0.2重量%存在。 在本發明新調配物之另一實施例中,當酸性聚合物為上 述類型時,其結構中包含相鄰的 137186.doc 12 200942167 -[-CR1.CO〇H-]- 單元(其中R係如上疋義)’例如基於馬來酸部分的聚合 物,其一般包含-[-CH.COOH-CH.COOH·]-單元及/或此等 單元之鹽或醋’或包含酐形式之此等單元,其中相鄰碳原 子上之COOH基團可環化形成 :。文。
_ 環系統’諸如上述可以商品名稱Gantrez™(例如GantrezTM S97)購得的聚合物,酸性聚合物及陰離子界面活性劑係適 宜地以酸性聚合物:陰離子界面活性劑重量%之比為3:丄_ 1:2共存於溶液中。在溶液中,酸性聚合物宜以I—?重量% 存在,及陰離子界面活性劑係以1 _6,而以3+/-0.2重量%為 - 宜。 • 本發明之新調配物較佳具有於2-4之間的pH。此可例如 在溶液中利用適宜的pH緩衝劑而達成。一適宜的緩衝劑可 ·++ 错由包含一或多種有機羧酸,諸如檸檬酸(其為較佳)、水 楊酸、富馬酸、苯甲酸、戊二酸、乳酸、丙二酸、醋酸' , 幾基乙酸、蘋果酸、己二酸、琥珀酸、天門冬胺酸、鄰苯 . 二甲酸、酒石酸、麵胺酸、焦麵胺酸、或葡糖酸、或其兩 種或多種之混合物而提供。可額外地或替代地包含一驗 (諸如氫氧化鈉)或一無機酸(諸如鹽酸),以達到適宜的pH 值。 一適宜的液體媒劑為水性媒劑,例如水、或乙醇、或乙 137186.doc -13· 200942167 醇與水之混合物。 可在4:1 -1:1 · 5之間 例如在此混合物中,乙醇:水之體積比 ’一般在3:1-1:1之間。 本發明之新消毒調配物可呈流動液體之形態,或者可呈 純凝膠之形態。例如,經發現上述的交聯聚领酸)聚合 物為以(例如)新戊四醇、廉糖或丙稀的稀丙醚交聯的丙烯 酸之均聚物,例如可購自BFG(K)driel^司的商品名稱 「―」的㈣’諸如特定的C—包含Carbopol 934、940、980、1382、Carb〇p〇1 ETD 2〇2〇、Ετ〇 2〇5〇、
Ultrez 20及2卜其傾向於與陰離子界面活性劑結合形成凝 膠。文中術語「液體」涵蓋此流動凝膠。此凝膠可有利於 使分配消毒調配物及其施用於皮膚容易。 相對地’於其結構中包含單元: -[-CR】R2-CR3R4-CR5.COOH-CR6,CO〇H-]- 之聚合物’其中Rl、R2、R3、R4、RjR6獨立地為氫(較 佳)或Cw燒基或C!-3烧氧基’ R1及R2較佳為氫,R3為氫, R為甲氧基’及R5及r6為氫’或於其結構中保留c〇〇H基 團、或易水解為COOH基團之基團的其之衍生物,諸如前 述可以商品名稱Gantrez™購得的聚合物,傾向於維持為流 動液體。 本發明調配物可包括其他物質以增強其效力,提供其它 功能’或對於特殊用途之適用性。 例如,調配物可包括一或多種額外的抗菌物質。 已知择橡酸具有抗病毒活性,當其存在於本發明調配物 中時’除pH控制功能外,其尚可表現該抗病毒作用。本發 137186.doc • 14- 200942167 明調配物一般可包含〇 I s 0.5-7/〇,通常 ^5+/-0.25 重量 0/〇之檸檬 酸。 本I月之較佳調配物較佳包含上述聚羧酸類型之 酸性聚合物、降雜工w t τ離子界面活性劑及檸檬酸;該酸性聚合物 於其結構中包含相鄰的 -[-CR'.COOH-]- 單元(/、中R係如上定義),例如基於馬來酸部分之聚合 物。。其般包含-[-CH.COOH-CH.COOH-]-單元、及/或此 等早兀之鹽或酯、或酐形式之此等單元,纟中相鄰碳原子 上之COOH基團可環化形成
環系統,此類衍生物易水解形成相應的游離酸。 因此本發明之—較佳調配物包含ι·5-〇·5重量〇/〇 Gantrez S-97、1·2重量%院基硫酸鈉(諸如月桂基硫酸 鈉)、及0.5 -1.5重量%棒檬酸。 因此,本發明之另一較佳調配物包含3.5-2.5重量% G:ntrezTM S_97、6_4重量%、較佳為4 5 5 5重量%之以·婦煙 磺酸鹽(諸如BiotergeAs-40)、及2.5-1.5重量%檸檬酸。 其他適宜的抗菌物質包含麝香草酚(抗真菌)、三氯生、 一或多種亞硫酸鹽(諸如亞硫酸鈉)、_或多種鋅鹽(諸如氣 化鋅)、一或多種已知具有抗菌活性之烷基或芳基銨鹽(諸 如市售材料Hyamine™’其主要包含二甲节基氣化銨,或 137186.doc 15 200942167 BTC 2125,其包含正烷基二甲基苯甲基氣化銨及正烷基二 甲基乙基苯甲基氯化銨)、三醋精(抗真菌)及山梨酸。 例如,調配物可包含一或多種螯合物質(諸如市售材料 VersenolTM)。 例如,調配物可包含一種螢光標記物,例如,其在紫外 光下可見地發光且可能殘留於其所施用之表面上,因此可 檢查(例如)在醫院環境中使用消毒調配物之順從性。此螢 光著色劑之一實例為二苯乙烯基聯苯二磺酸二鈉或8_羥基_ 1,3,6-芘績酸三鈉鹽(ci 59040)。 因此,本發明之另一態樣提供以新穎之消毒調配物消毒 一表面(尤其是使用者之皮膚)之用途,尤其用於消毒被潛 在有害之微生物(例如細菌或病毒)污染或據信受其污染之 表面。 在此用途中,調配物可以習知方式使用,經由將其施用 於表面或手本身上,例如傾倒或噴霧於表面上,或可將表 面浸入調配物中,或可將調配物吸收於(例如)海綿、布料 或薄紙專上並利用其施用於表面。 在本發明之第四態樣巾,提供此處之消毒調配物以用作 用於一表面的消毒調配物,尤其係用作用於使用者之皮膚 (例如手)的消毒調配物。對於該用途,調配物較佳係提供 在利於施用至表面的分配器中,例如容納於分配容器中或 於此分配容器之補充物中…般而t ’對㈣爲皮膚消毒 調配物之用途,新穎調配物可提供於具有可手操作泵之容 器中。 137186.doc .16- 200942167 文中揭示之調配物可藉由習知步驟製備:將成分(例如 酸性聚合物、pH緩衝物質、陰離子界面活性劑、若存在之 諸如UV螢光著色劑之其他物質、及液體媒劑)混合在一 起,且攪拌該混合物直至全部溶解。較佳先將酸性聚合物 分散於液體媒劑中,然後再混入陰離子聚合物及其他成 分。若預期酸性聚合物及陰離子界面活性劑之混合會導致 混合物的膠凝,則上述的成分添加順序可能相當重要。 本發明之另一態樣提供一種適於經液體媒劑稀釋從而提 供文中所述之消毒調配物之濃縮物。該濃縮物可包含適宜 為1-2:2-1之重量%比、較佳為1:1.5 +/_ 〇·2之酸性聚合物與 離子型界面活性劑的混合物。該濃縮物亦可包含諸如上述 有機羧酸及鹼中之一或多種之材料,使得經稀释之配製消 毒調配物pH具有所需之pH ’例如2-4。此濃縮物可於適宜 容器中提供使用。 【實施方式】
以下本發明僅藉由實例敍述。 實例1 酸性聚合物: 界面活性劑: 有機羧酸: pH調節劑:
Carbopol ETD 2020 2% w/w 月桂基硫酸鈉1.5 % w/w 檸樣酸1 % w/w 氫氧化鈉調至pH 3 水加至100% 實例2 酸性聚合物: Gantrez S97 1% w/w 137186.doc -17- 200942167 界面活性劑: 月桂基硫酸納1.5 °/〇 w/w 有機羧酸: 檸檬酸1 % w/w pH調節劑: 氫氧化鈉調至pH 3 水加至100% 體外抗菌效力之評估 利用依據歐洲藥典及美國藥典中所述之微生物保存效力 試驗方法的懸浮液測試評估上述消毒調配物之樣品。 使用之生物 大腸桿菌NCIMB 8545 金黃色葡萄球菌NCIMB 9518 步驟 將4.5ml調配物與0·5ml細菌懸浮液(107CFU/ml)合併。 1分鐘後,移除1 ml之混合溶液且以9 ml中和培養基(含有 10% Tween 20與3%卵磷脂之胰蛋白腺大豆肉湯)稀釋。進 行連續稀釋且使用1 ml傾注平板法計算存活微生物數目。 結果係以平均CFU/ml表示。經由比較在添加至產物前之細 菌懸浮液之初始對數(log)值與暴露1分鐘後之值來計算對 數減少量。 體外殺病毒活性之評估 利用ASTM E1052中所述之方法評估以上消毒調配物之 樣品。 使用之病毒 流感 A/Hong Kong 8/68 ATTC544/GBL 44540、pool #3 參 照號 744-239-112 137186.doc -18- 200942167 步驟 將0.1 ml生物加至0.9 ml樣品中且使其在20-25°C下保持 接觸10分鐘。將該接種樣品於中和培養基中稀釋1 〇-1至1 〇_ 分析樣品及經由比較添加產物前之初始值與暴露1〇分 鐘後之值來計算病毒效價之對數減少量。 結果 樣品 流感A Log減少量 @10分鐘 (EID50/0.1 ml) N=4 Log減少量 金黃色葡萄球 菌@1分鐘 ~~----- Log減少量 大腸桿菌 實例1 5.5 >5.5 鐘 實例2 5.5 >5.5 ^5 低佩不贫明之消每洛液之進- -步實例列示 於下。 實例3 重量% Gantrez S-97BF 13%溶液 23.10 Bioterge As-40* 5.00 檸檬酸 2.00 Versenol 120** (41%) 0.25 醇(未變性)95% 66.75 鹽酸0.5 N 1.40 三醋精 1.50 pH(按現狀) 2.61 合計 100.00 137186.doc 19 200942167 實例4 重量% Gantrez S-97BF 13%溶液 23.10 Bioterge As-40 5.00 檸檬酸 2.00 Versenol 120 (41%) 0.25 醇(未變性)95% 63.40 氯化鋅 0.25 氫氧化鈉0.5 N 4.50 三醋精 1.50 pH(按現狀) 2.60 合計 100.00 *VersenolTM 120螯合劑為N-(羥乙基)乙二胺三乙酸三鈉鹽 之水溶液。 **Bioterge As 40為在酸性pH下穩定的α-烯煙績酸目旨之納 鹽。在該調配物中使用陰離子含量。 137186.doc 20-
Claims (1)
- 200942167 七、申請專利範圍: 1. 一種消毒調配物,其包含一酸性聚合物與一陰離子界面 活性劑於一液體媒劑中之溶液。 2. 如請求項1之消毒調配物,其中該酸性聚合物包含聚-(羧 酸)聚合物。 3. 如請求項2之消毒調配物,其中該酸性聚合物包含經新 , 戊四醇、蔗糖或丙烯之烯丙醚交聯之丙烯酸均聚物。 4. 如請求項3之消毒調配物,其中該酸性聚合物包含 • Carbopol ETD 2020。 5·如請求項2之消毒調配物,其中該酸性聚合物在其結構 中包含相鄰的 -[-CR1.COOH-]- 單元’其中R1為氫或C13烷基或Cl_3烷氧基。 6 _如。青求項5之消毒調配物,其中該酸性聚合物在其結構 中包含單元: Φ +Cr1r2-CR3R4-CR5.COOH-CR6.COOH·]- 其中R1、R2、R3、R4、R5及R6獨立地為氫或Ci3燒基或 Ci-3燒氡基。 7.如叫求項5或6之消毒調配物,其中該酸性聚合物係基於 • 馬來酸都八 1 刀’其包含-[-CH.COOH-CH.COOH-]-單元及/ 或此*箄置-> & * 早疋之鹽或酯、或呈酐形式之此等單元(其中相鄰 石反原子上之c〇〇H基團經環化形成 137186.doc 200942167 °tc 二先)lit等衍生物易水解形成相應的游離酸。 4月求項6之消毒調配物’其中RjR2為氫,r3為氯, 為甲氧基’及R及R6為氫或保持⑶〇H基團於其結 構:之其衍生物、或易水解成COOH基之基團。 如。月求項8之消毒調配物,其中該酸性聚合物為基於甲 基=稀基趟與馬來針之共聚物之聚领酸)聚合物。 10. 如明求項9之消毒調配物,其中該酸性聚合物包含聚合 物 GantrezTM S_97。 11. 如請求項〗至6及8至10中任一項之消毒調配物,其中該 陰離子界面活性劑為具有親水性陰離子基團及相關陽離 子之化合物。 12. 如明求項11之消毒調配物,其中該陰離子界面活性劑係 選自月桂基硫酸鈉、月桂基醚礙酸鈉及α_稀烴硫酸鹽。 13. 如s青求項12之消毒調配物,其包含carb〇p〇1TM ETD 2020 或GantrezTM S97、以及月桂基硫酸鈉或心烯烴硫酸鹽。 14·如請求項1至6及8至10中任一項之消毒調配物,其中該 酸性聚合物與該陰離子界面活性劑係以酸性聚合物:陰 離子界面活性劑之重量%為1-2:2-1之比例共存於溶液 中〇 15.如请求項5、6及8至10中任一項之消毒調配物,其中該 酸性聚合物與該陰離子界面活性劑係以酸性聚合物:陰 離子界面活性劑之重量%為3 :1 -1:2之比例共存於溶液 137186.doc 200942167 中ο 16 ·如明求項1 5之消毒調配物,其中該酸性聚合物係以1 -7重 里/°存在,及該陰離子界面活性劑係以1 -6重量%存在。 17. 如响求項1至6及8至10中任一項之消毒調配物,其中ρΗ 值係介於2-4之間。 18. 如叫求項5、6及8至10中任一項之消毒調配物,其中該 • 調配物係存於包含乙醇:水之體積比為4:1-1:1.5之乙醇 _ 與水之混合物的液體媒劑中。 19. 如凊求項18之消毒調配物,其係呈流動液體形態,或呈 黏性凝膠形態。 20. 如請求項!至6及8至1〇中任一項之消毒調配物,其包含 擰檬酸。 2 1.如叫求項2 〇之消毒調配物其包含〇 $ _ 7重量。/。之捧棟 酸。 ,22·如請求項1至0及8至10中任一項之消毒調配物,其包含 Φ 在其結構中含相鄰的 -[-CR1.CO〇H-]- 單疋(其中R1係如上定義)之酸性聚合物、陰離子界面泠 • 性劑及檸檬酸。 • 23·如清求項22之消毒調配物,其包含1.5-0.5重量〇/〇 GantrezTM S_97、1-2重量%月桂基硫酸鈉、及on 5重耋 %棒樣酸。 24·如請求項22之消毒調配物,其包含3.5-2.5重量〇/〇 GantreZ™ S-97、6-4重量% α·烯烴磺酸鹽、及2.5-1·5重 137186.doc 200942167 量%檸檬酸β 25. 26. 27. 一種如請求項1至24中任一堪、、, 在有害微生物(例如細菌或病物於消毒受潛 表面之用途。 扃毒冶染或據信受其污染之 如请求項1至6及8至1〇中杯一 TS L 中任一項之消毒調配物,其係經 提供用仙於-表面之料航物。 一種遭縮物’其適於經一液體媒劑稀釋從而提供如請求 項1至24中任一項之消毒調配物。 137186.doc 200942167 四、指定代表圖: (一) 本案指定代表圖為:(無) (二) 本代表圖之元件符號簡單說明: 五、本案若有化學式時,請揭示最能顯示發明特徵的化學式: (無)137186.doc
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0800788.2A GB0800788D0 (en) | 2008-01-16 | 2008-01-16 | Niovel formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200942167A true TW200942167A (en) | 2009-10-16 |
Family
ID=39165873
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW098101274A TW200942167A (en) | 2008-01-16 | 2009-01-14 | Novel formulation |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8491878B2 (zh) |
| EP (1) | EP2237662A1 (zh) |
| JP (1) | JP2011511764A (zh) |
| KR (1) | KR20100119769A (zh) |
| CN (1) | CN101917842A (zh) |
| AR (1) | AR070166A1 (zh) |
| AU (1) | AU2009204852A1 (zh) |
| BR (1) | BRPI0907188A2 (zh) |
| CA (1) | CA2711980A1 (zh) |
| CO (1) | CO6280436A2 (zh) |
| GB (1) | GB0800788D0 (zh) |
| MX (1) | MX2010007864A (zh) |
| NZ (1) | NZ586757A (zh) |
| TW (1) | TW200942167A (zh) |
| WO (1) | WO2009090178A1 (zh) |
| ZA (1) | ZA201004772B (zh) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2278972B1 (en) * | 2008-05-30 | 2018-04-11 | Psychogenics Inc. | Treatment for neurological and mental disorders |
| US11076187B2 (en) | 2015-05-11 | 2021-07-27 | Mediamelon, Inc. | Systems and methods for performing quality based streaming |
| WO2018160818A1 (en) | 2017-03-01 | 2018-09-07 | Ecolab Usa Inc. | Reduced inhalation hazard sanitizers and disinfectants via high molecular weight polymers |
| US11026422B2 (en) | 2017-09-26 | 2021-06-08 | Ecolab Usa Inc. | Acid/anionic antimicrobial and virucidal compositions and uses thereof |
| JP7421903B2 (ja) * | 2019-10-25 | 2024-01-25 | 花王株式会社 | ウイルス不活性化剤組成物 |
| MX2022007352A (es) | 2019-12-16 | 2022-09-12 | Ecolab Usa Inc | Impacto del tensioactivo aniónico en la eficacia viricida. |
| GB2637898A (en) * | 2023-10-11 | 2025-08-13 | Residual Barrier Tech Limited | Surface disinfectant |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3141821A (en) * | 1959-03-17 | 1964-07-21 | Lehn & Fink Products Corp | Synergistic combination of alkyl sulfonates, alkylaryl sulfonates and topical antibacterial agents for local antisepsis |
| US4404040A (en) * | 1981-07-01 | 1983-09-13 | Economics Laboratory, Inc. | Short chain fatty acid sanitizing composition and methods |
| US4514385A (en) * | 1981-10-05 | 1985-04-30 | Alcon Laboratories, Inc. | Anti-acne compositions |
| LU84752A1 (fr) * | 1983-04-15 | 1984-11-28 | Oreal | Composition lavante et moussante a base d'agents tensio-actifs et de polymeres anioniques |
| GB9619682D0 (en) * | 1996-09-20 | 1996-11-06 | Unilever Plc | Improvements relating to antimicrobial cleaning compositions |
| US6190675B1 (en) * | 1997-06-04 | 2001-02-20 | Procter & Gamble Company | Mild, rinse-off antimicrobial liquid cleansing compositions which provide improved residual benefit versus gram positive bacteria |
| US6287577B1 (en) * | 1997-11-12 | 2001-09-11 | The Procter & Gamble Company | Leave-on antimicrobial compositions which provide improved residual benefit versus gram positive bacteria |
| US6287583B1 (en) * | 1997-11-12 | 2001-09-11 | The Procter & Gamble Company | Low-pH, acid-containing personal care compositions which exhibit reduced sting |
| US6109675A (en) * | 1998-06-23 | 2000-08-29 | Waltco Truck Equipment Co. | Hinged member for a rear impact guard |
| CA2338586A1 (en) * | 1998-08-14 | 2000-02-24 | L'oreal S.A. | Stable cleansing compositions containing active agents |
| US6146622A (en) * | 1998-10-27 | 2000-11-14 | Alcon Laboratories, Inc. | Use of certain anionic amino acid based surfactants to enhance antimicrobial effectiveness of topically administrable pharmaceutical compositions |
| EP0997525A1 (en) * | 1998-10-30 | 2000-05-03 | The Procter & Gamble Company | Process of cleaning carpets with a composition comprising a poly (vinyl methyl ether/maleic acid) copolymer |
| GB2354008A (en) * | 1999-09-09 | 2001-03-14 | Mcbride Robert Ltd | Personal hygiene product |
| US6953772B2 (en) * | 2000-07-18 | 2005-10-11 | Lopes John A | Concentrated sanitizing compositions for cleaning food and food contact surfaces |
| US6828294B2 (en) * | 2001-08-07 | 2004-12-07 | Fmc Corporation | High retention sanitizer systems |
| GB2391810A (en) * | 2002-08-14 | 2004-02-18 | Reckitt Benckiser Inc | Disinfectant with residual antimicrobial activity |
| GB2393908A (en) | 2002-10-12 | 2004-04-14 | Reckitt Benckiser Inc | Thickened, abrasive containing, liquid disinfectant |
| DE112004000721T5 (de) * | 2003-05-07 | 2006-11-09 | Ajinomoto Co., Inc. | Reinigungszusammensetzung |
| GB0310974D0 (en) | 2003-05-13 | 2003-06-18 | Unilever Plc | Fabric conditioning compositions |
| GB0311174D0 (en) | 2003-05-15 | 2003-06-18 | Baker Brian F | Anti-viral cleaning composition |
| US20050271717A1 (en) * | 2003-06-12 | 2005-12-08 | Alfred Berchielli | Pharmaceutical compositions of atorvastatin |
| ITVR20030086A1 (it) | 2003-07-11 | 2005-01-12 | Silmar Spa | Procedimento per produrre semilavorati compositi in lega preziosa |
| US20050049172A1 (en) * | 2003-08-28 | 2005-03-03 | Lukenbach Elvin R. | Mild and effective cleansing compositions |
| US20050201965A1 (en) * | 2004-03-11 | 2005-09-15 | The Procter & Gamble Company | Personal cleansing compositions |
| US20050271711A1 (en) * | 2004-04-26 | 2005-12-08 | The Procter & Gamble Company | Therapeutic antimicrobial compositions and methods |
| GB0410968D0 (en) | 2004-05-17 | 2004-06-16 | Greenbridge Environmental Cont | Skin cleaning composition |
| JP2008523064A (ja) * | 2004-12-09 | 2008-07-03 | ザ ダイアル コーポレイション | 優れた抗ウィルス作用と抗菌作用を示す組成物 |
| CA2654079A1 (en) * | 2006-06-02 | 2008-03-27 | The Dial Corporation | Method of inhibiting the transmission of influenza virus |
| US8318654B2 (en) * | 2006-11-30 | 2012-11-27 | Kimberly-Clark Worldwide, Inc. | Cleansing composition incorporating a biocide, heating agent and thermochromic substance |
-
2008
- 2008-01-16 GB GBGB0800788.2A patent/GB0800788D0/en not_active Ceased
-
2009
- 2009-01-14 US US12/353,280 patent/US8491878B2/en not_active Expired - Fee Related
- 2009-01-14 TW TW098101274A patent/TW200942167A/zh unknown
- 2009-01-14 AR ARP090100109A patent/AR070166A1/es not_active Application Discontinuation
- 2009-01-14 CA CA2711980A patent/CA2711980A1/en not_active Abandoned
- 2009-01-14 CN CN2009801024797A patent/CN101917842A/zh active Pending
- 2009-01-14 WO PCT/EP2009/050337 patent/WO2009090178A1/en not_active Ceased
- 2009-01-14 JP JP2010542613A patent/JP2011511764A/ja active Pending
- 2009-01-14 EP EP09702055A patent/EP2237662A1/en not_active Withdrawn
- 2009-01-14 BR BRPI0907188-1A patent/BRPI0907188A2/pt not_active IP Right Cessation
- 2009-01-14 NZ NZ586757A patent/NZ586757A/en not_active IP Right Cessation
- 2009-01-14 AU AU2009204852A patent/AU2009204852A1/en not_active Abandoned
- 2009-01-14 MX MX2010007864A patent/MX2010007864A/es unknown
- 2009-01-14 KR KR1020107018142A patent/KR20100119769A/ko not_active Withdrawn
-
2010
- 2010-07-06 ZA ZA2010/04772A patent/ZA201004772B/en unknown
- 2010-07-08 CO CO10082877A patent/CO6280436A2/es active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| GB0800788D0 (en) | 2008-02-27 |
| WO2009090178A1 (en) | 2009-07-23 |
| AR070166A1 (es) | 2010-03-17 |
| US8491878B2 (en) | 2013-07-23 |
| BRPI0907188A2 (pt) | 2015-07-14 |
| AU2009204852A1 (en) | 2009-07-23 |
| EP2237662A1 (en) | 2010-10-13 |
| CN101917842A (zh) | 2010-12-15 |
| US20090208444A1 (en) | 2009-08-20 |
| JP2011511764A (ja) | 2011-04-14 |
| KR20100119769A (ko) | 2010-11-10 |
| MX2010007864A (es) | 2010-08-09 |
| CO6280436A2 (es) | 2011-05-20 |
| NZ586757A (en) | 2012-06-29 |
| ZA201004772B (en) | 2011-12-28 |
| CA2711980A1 (en) | 2009-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4995406B2 (ja) | 皮膜形成性組成物および方法 | |
| JP4663983B2 (ja) | 消毒用組成物および方法 | |
| TW200942167A (en) | Novel formulation | |
| CA2666146A1 (en) | Methods of inactivating viruses | |
| AU2003245498B2 (en) | Enhanced activity hydrogen peroxide disinfectant | |
| RU2685707C2 (ru) | Антимикробные композиции | |
| US20070258915A1 (en) | Anti-Microbial Composition and Method for Making and Using Same | |
| CN102908362A (zh) | 抗菌组合物和使用方法 | |
| JP2001503415A (ja) | 即使用可能なグルタルアルデヒド濃縮物 | |
| FR2667220A1 (fr) | Composition d'agent nettoyant-decontaminant notamment pour instruments chirurgicaux. | |
| WO1992006694A1 (en) | Antimicrobial hydrogels | |
| JP2556973B2 (ja) | 防腐剤組成物 | |
| TW201111457A (en) | Novel article | |
| TWI326603B (en) | Method for disinfecting or sanitizing a surface | |
| CN1142264C (zh) | 一种完全可水溶解性洗手膜 | |
| CN118055697A (zh) | 抗微生物组合物以及包含该抗微生物组合物的配制品 | |
| JP4689619B2 (ja) | 高分子安定剤を含む抗菌性組成物 | |
| JPH04305504A (ja) | 粘稠状殺菌剤組成物 | |
| RU2359656C1 (ru) | Средство для сухой дезинфекции и очистки рук | |
| JP2008115125A (ja) | 消毒用速乾性透明ローション | |
| CN101453889A (zh) | 用于控制类诺瓦克病毒传染的组合物和方法 | |
| SU1759863A1 (ru) | Биологически активна композици дл гигиены туалетных помещений и освежени воздуха | |
| JPH06256104A (ja) | 抗菌性持続型消毒剤 |